Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cure Urgent Care is a private healthcare services company that operates walk-in urgent care clinics in the New York market. The company provides immediate, non-emergency medical care including sick visits, flu shots, COVID-19 testing, bloodwork, and other routine urgent care services for adults and children. It was founded in 2014 and has been described as a locally owned medical practice serving New York City and Long Island residents. Public sources identify Jake Deutsch as Clinical Director and Elan Katz as a business owner/executive associated with the company. Cure Urgent Care is a care delivery business rather than a drug-development biotech or pharmaceutical company, and its value proposition centers on convenient access, consumer-friendly urgent care, and retail-style outpatient operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cure Urgent Care.